ArticlePloS one2023

Development and characterization of nanobodies that specifically target the oncogenic Phosphatase of Regenerating Liver-3 (PRL-3) and impact its interaction with a known binding partner, CNNM3.

Caroline N Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.